Manjasetty Babu A, Niesen Frank H, Delbrück Heinrich, Götz Frank, Sievert Volker, Büssow Konrad, Behlke Joachim, Heinemann Udo
Protein Structure Factory, c/o BESSY GmbH, Albert-Einstein-Str. 15, D-12489 Berlin, Germany.
Biol Chem. 2004 Oct;385(10):935-42. doi: 10.1515/BC.2004.122.
The human protein FLJ36880 belongs to the fumarylacetoacetate hydrolase family. The X-ray structure of FLJ36880 has been determined to 2.2 A resolution employing the semi-automated high-throughput structural genomics approach of the Protein Structure Factory. FLJ36880 adopts a mixed beta-sandwich roll fold and forms homodimers in crystals as well as in solution. One Mg2+ ion is bound to each subunit of the dimeric protein by coordination to three carboxylate oxygens and three water molecules. These metal binding sites are accessible from the same surface of the dimer, partly due to the disorder of the undecapeptide stretch D29 to L39. The overall structure and metal binding site of FLJ36880 bear clear similarities to the C-terminal domain of the bifunctional enzyme HpcE from Escherichia coli C, fumarylacetoacetate hydrolase from Mus musculus and to YcgM (Apc5008) from E. coli 1262. These similarities provide a framework for suggesting biochemical functions and evolutionary relationships of FLJ36880. It appears highly probable that the metal binding sites are involved in an enzymatic activity related to the catabolism of aromatic amino acids. Two point mutations in the active-site of FAH, responsible for the metabolic disease hereditary tyrosinemia type I (HTI) in humans, affect residues that are structurally conserved in FLJ36880 and located in the putative catalytic site.
人类蛋白质FLJ36880属于富马酰乙酰乙酸水解酶家族。采用蛋白质结构工厂的半自动高通量结构基因组学方法,已确定FLJ36880的X射线结构分辨率为2.2埃。FLJ36880采用混合β-三明治卷状折叠结构,在晶体和溶液中均形成同源二聚体。一个Mg2+离子通过与三个羧酸根氧原子和三个水分子配位,与二聚体蛋白质的每个亚基结合。这些金属结合位点可从二聚体的同一表面进入,部分原因是十一肽片段D29至L39的无序性。FLJ36880的整体结构和金属结合位点与来自大肠杆菌C的双功能酶HpcE的C末端结构域、小家鼠的富马酰乙酰乙酸水解酶以及来自大肠杆菌1262的YcgM(Apc5008)有明显相似之处。这些相似性为推测FLJ36880的生化功能和进化关系提供了框架。金属结合位点极有可能参与与芳香族氨基酸分解代谢相关的酶活性。人类遗传性酪氨酸血症I型(HTI)代谢疾病所涉及的FAH活性位点的两个点突变,影响了FLJ36880中结构保守且位于假定催化位点的残基。